Authors' Response to Association between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease

We thank Naharci and Tasci1 for their thoughtful comments regarding our recent article published in the Journal of the American Medical Directors Assoication.2 They provided us with an opportunity to further increase the clinical value of our finding relating to the association between acetylcholinesterase inhibitors (AChEIs) and risk of fracture in patients with Alzheimer's disease (AD).